TargEDys' partners

Our partners

Our mission being to detect, transpose and make available microbiome-based innovations addressing global public health issues, our success depends on our partners – R&D partners for the establishment of the science, industrial partners for the products to exist, and business partners for global market access and promotion.

1. Research and development partners


A long-standing partner of TargEDys, the National Institute for Health and Medical Research (Inserm) is behind the 20 years of research that resulted in the creation of the company in partnership with the Rouen University Hospital.
Founders of TargEDys Professors Déchelotte and Fetissov come from the Inserm laboratory in Rouen.

More recently, Inserm is continuing research in the area of stress and anxiety with TargEDys.

CHU Rouen

The University Hospital of Rouen (CHU) is the second founding Institution of TargEDys.

Being associated with a hospital is a great opportunity to link product development to the reality of clinical practice and needs.


The most recent partner of TargEDys, the Institute of Functional Genomics in Lyon (IGFL) is specialized in studying bacterial strains in the sphere of optimization of nutrition and growth. L. plantarum WJL comes from this collaboration and promotes growth in juveniles.

2. Distribution partners

Biocodex, France, Portugal & Poland

Biocodex is an independent multinational pharmaceutical company built on high- standard science and manufacturing, with six decades of proven success. Founded in 1953, the company’s initial focus was gastroenterology featuring a unique probiotic Saccharomyces boulardii CNCM I-745®, the first probiotic drug of its kind that has a positive effect on gut health.

PharmExtracta, Italy

PharmExtracta, the flagship of bacterial therapy, is a family-owned company with over 30 years of experience in the pharmaceutical and nutraceutical sector and an established expert in the probiotic and phytotherapy space, with a focus on innovative formulations, backed by cutting-edge science published in the most important peer-rewied journals. The strategy of PharmExtracta is to focus on medical promotion, with a constant exchange with the specialists, including with a strong educational approach such as through the PharmExtracta Campus and webinars.

Medilab One, Croatia & Bosnia

"Balance, our way of life"
Medilab One is a leader in diabetes monitoring products and exclusive distributor of high-quality diabetes and chronic disease products of well-known global brands. With a strong reputation built on quality, reliability, and innovation, Medilab One strives to enable complete solutions and improve people’s quality of life, investing efforts to support the users of their products find the right balance between the burden of living with a disease and enjoying their everyday life. In respect to healthcare professionals, the strategy of Medilab One is primarily focused on providing support and medical communication, as well as nurturing a strong relationship with endocrinologists, nutritionists, and weight management clinics. The company will complete the communication approach with visits to pharmacists, and direct to consumer messages.

SymbioPharm, Germany

SymbioPharm GmbH is a pioneer in microbiome research and knowledge-based probiotics - since 1954. Its mission is to preserve health and to heal diseases with probiotic bacteria – making use of purely biological effect of natural bacteria. Therefore, it researches the human microbiome and develops innovative microbiological therapy approaches. The company holds a state-of-the-art production facility, and showcases comprehensive expertise from diagnostics – with the Institute for Microecology – to innovative solutions.

This website uses different types of cookies to enable, improve and monitor the use of our website. For more information see our cookie policy
By clicking accept or continuing to browse on our website, you consent to the use on your device of analytics, advertising and other tags/files.
Read about